Rowasa 4 g/60mL (Mesalamine SUSPENSION) 4 g/60mL

Rowasa 4 g/60mL is a rectal suspension containing mesalamine, used for managing inflammatory conditions in the colon. This medication is designed for localized treatment, offering a targeted approach to symptom relief.

Strength

4 g/60mL

Pack Size

7 BOTTLE, DISPENSING in 1 CARTON (0037-0066-05) / 60 mL in 1 BOTTLE, DISPENSING (0037-0066-06)

Manufacturer / TM Owner

Viatris Specialty LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Rowasa 4 g/60mL is primarily used for the treatment of ulcerative proctitis, a type of inflammatory bowel disease affecting the rectum. Mesalamine, the active ingredient, helps to reduce inflammation in the colon. This medication is often recommended for individuals experiencing symptoms such as rectal bleeding, diarrhea, and abdominal pain. It is administered rectally, allowing the active ingredient to act directly on the affected area.

Side Effects

Common effects of Rowasa 4 g/60mL may include mild abdominal cramps, bloating, or gas. Some users might experience rectal irritation or discomfort. These effects are generally temporary and should subside as the body adjusts to the medication. If severe or persistent, it is advisable to consult a healthcare provider.

Precautions & Warnings

Rowasa 4 g/60mL should be used with caution in individuals with known allergies to mesalamine or other ingredients in the suspension. It is important to follow the prescribed administration instructions to ensure proper use. Keep the medication out of reach of children and store it as directed to maintain its effectiveness.

Avoid Interactions

Rowasa 4 g/60mL may interact with certain medications, including nonsteroidal anti-inflammatory drugs (NSAIDs) and other drugs that affect the gastrointestinal tract. Alcohol consumption should be avoided as it may exacerbate side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Rowasa 4 g/60mL is used for the treatment of ulcerative proctitis, helping to reduce inflammation in the rectum.

Rowasa 4 g/60mL is administered rectally, typically using the provided dispensing bottle for accurate dosage.

Common side effects may include abdominal cramps, bloating, gas, and rectal irritation.

It is important to consult a healthcare provider before using Rowasa 4 g/60mL with other medications to avoid potential interactions.

Rowasa 4 g/60mL should be stored as directed on the packaging, typically at room temperature and away from moisture.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.